Winner Medical (300888) Fundamentals 2026 — P/E 22.7x, Revenue Analysis | SniperIQ
Winner Medical (300888) is a CN-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥17.6B, trading at ¥30.18 on the SHZ. This SniperIQ fundamentals page covers Winner Medical's valuation (P/E 22.7x, P/B 1.5x), profitability (net margin 7.0%), revenue (¥10.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Winner Medical's market cap?
Winner Medical (300888) has a market capitalization of approximately ¥17.6B, trading at ¥30.18 on the SHZ. Market cap moves with the live share price.
What is Winner Medical's P/E ratio?
Winner Medical's trailing twelve-month P/E ratio is 22.7x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Winner Medical?
Winner Medical runs a net profit margin of 7.0%, a gross margin of 46.7%, and an operating margin of 11.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Winner Medical generate?
Winner Medical reported revenue of ¥10.9B for fiscal year 2025, with net income of ¥768M and earnings per share (EPS) of 1.32. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Winner Medical pay a dividend?
Winner Medical offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Winner Medical financially healthy?
Winner Medical carries a debt-to-equity ratio of 0.30x and a current ratio of 1.86x, with a market beta of 0.09. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Winner Medical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Winner Medical (300888) the key facts are: market cap ¥17.6B, P/E 22.7x, revenue ¥10.9B, 52-week range 26.09-43.88. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Winner Medical's full fundamentals live
Get Winner Medical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.